IBDEI052 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1687,1,4,0)
 ;;=4^H35.52
 ;;^UTILITY(U,$J,358.3,1687,2)
 ;;=^5005697
 ;;^UTILITY(U,$J,358.3,1688,0)
 ;;=H35.53^^16^167^34
 ;;^UTILITY(U,$J,358.3,1688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1688,1,3,0)
 ;;=3^Sensory Retina Dystrophies
 ;;^UTILITY(U,$J,358.3,1688,1,4,0)
 ;;=4^H35.53
 ;;^UTILITY(U,$J,358.3,1688,2)
 ;;=^268656
 ;;^UTILITY(U,$J,358.3,1689,0)
 ;;=H40.9^^16^167^14
 ;;^UTILITY(U,$J,358.3,1689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1689,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,1689,1,4,0)
 ;;=4^H40.9
 ;;^UTILITY(U,$J,358.3,1689,2)
 ;;=^5005931
 ;;^UTILITY(U,$J,358.3,1690,0)
 ;;=H26.9^^16^167^4
 ;;^UTILITY(U,$J,358.3,1690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1690,1,3,0)
 ;;=3^Cataract,Unspec
 ;;^UTILITY(U,$J,358.3,1690,1,4,0)
 ;;=4^H26.9
 ;;^UTILITY(U,$J,358.3,1690,2)
 ;;=^5005363
 ;;^UTILITY(U,$J,358.3,1691,0)
 ;;=H17.9^^16^167^6
 ;;^UTILITY(U,$J,358.3,1691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1691,1,3,0)
 ;;=3^Corneal Scar & Opacity,Unspec
 ;;^UTILITY(U,$J,358.3,1691,1,4,0)
 ;;=4^H17.9
 ;;^UTILITY(U,$J,358.3,1691,2)
 ;;=^5005003
 ;;^UTILITY(U,$J,358.3,1692,0)
 ;;=H47.20^^16^167^19
 ;;^UTILITY(U,$J,358.3,1692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1692,1,3,0)
 ;;=3^Optic Atrophy,Unspec
 ;;^UTILITY(U,$J,358.3,1692,1,4,0)
 ;;=4^H47.20
 ;;^UTILITY(U,$J,358.3,1692,2)
 ;;=^5006126
 ;;^UTILITY(U,$J,358.3,1693,0)
 ;;=H47.091^^16^167^22
 ;;^UTILITY(U,$J,358.3,1693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1693,1,3,0)
 ;;=3^Optic Nerve Disorders,Right Eye
 ;;^UTILITY(U,$J,358.3,1693,1,4,0)
 ;;=4^H47.091
 ;;^UTILITY(U,$J,358.3,1693,2)
 ;;=^5006117
 ;;^UTILITY(U,$J,358.3,1694,0)
 ;;=H47.092^^16^167^21
 ;;^UTILITY(U,$J,358.3,1694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1694,1,3,0)
 ;;=3^Optic Nerve Disorders,Left Eye
 ;;^UTILITY(U,$J,358.3,1694,1,4,0)
 ;;=4^H47.092
 ;;^UTILITY(U,$J,358.3,1694,2)
 ;;=^5006118
 ;;^UTILITY(U,$J,358.3,1695,0)
 ;;=H47.093^^16^167^20
 ;;^UTILITY(U,$J,358.3,1695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1695,1,3,0)
 ;;=3^Optic Nerve Disorders,Bilateral
 ;;^UTILITY(U,$J,358.3,1695,1,4,0)
 ;;=4^H47.093
 ;;^UTILITY(U,$J,358.3,1695,2)
 ;;=^5006119
 ;;^UTILITY(U,$J,358.3,1696,0)
 ;;=H27.03^^16^167^1
 ;;^UTILITY(U,$J,358.3,1696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1696,1,3,0)
 ;;=3^Aphakia,Bilateral
 ;;^UTILITY(U,$J,358.3,1696,1,4,0)
 ;;=4^H27.03
 ;;^UTILITY(U,$J,358.3,1696,2)
 ;;=^5005367
 ;;^UTILITY(U,$J,358.3,1697,0)
 ;;=H27.01^^16^167^3
 ;;^UTILITY(U,$J,358.3,1697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1697,1,3,0)
 ;;=3^Aphakia,Right Eye
 ;;^UTILITY(U,$J,358.3,1697,1,4,0)
 ;;=4^H27.01
 ;;^UTILITY(U,$J,358.3,1697,2)
 ;;=^5005365
 ;;^UTILITY(U,$J,358.3,1698,0)
 ;;=H27.02^^16^167^2
 ;;^UTILITY(U,$J,358.3,1698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1698,1,3,0)
 ;;=3^Aphakia,Left Eye
 ;;^UTILITY(U,$J,358.3,1698,1,4,0)
 ;;=4^H27.02
 ;;^UTILITY(U,$J,358.3,1698,2)
 ;;=^5005366
 ;;^UTILITY(U,$J,358.3,1699,0)
 ;;=I69.998^^16^167^5
 ;;^UTILITY(U,$J,358.3,1699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1699,1,3,0)
 ;;=3^Cerebrovascular Disease,Unspec,Sequelae
 ;;^UTILITY(U,$J,358.3,1699,1,4,0)
 ;;=4^I69.998
 ;;^UTILITY(U,$J,358.3,1699,2)
 ;;=^5007572
 ;;^UTILITY(U,$J,358.3,1700,0)
 ;;=S04.011A^^16^167^26
 ;;^UTILITY(U,$J,358.3,1700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1700,1,3,0)
 ;;=3^Optic Nerve Injury,Right Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,1700,1,4,0)
 ;;=4^S04.011A
 ;;^UTILITY(U,$J,358.3,1700,2)
 ;;=^5020462
 ;;^UTILITY(U,$J,358.3,1701,0)
 ;;=S04.012A^^16^167^23
 ;;^UTILITY(U,$J,358.3,1701,1,0)
 ;;=^358.31IA^4^2
